Image default
Synthetic Biology Technology

Take a step inside the SynBio World Café.

The second SynBio World Café , ‘What stops the SynBio revolution in Germany?’ organised by the German Association for Synthetic Biology (GASB) with support of the Hightech-Forum, will take place on the 9th of July, 2020 10am – 6pm. Due to the current global health restrictions it will take place as a virtual event. But the team organising are confident there will be a comparable level of engagement and activity as the previous SynBio World Café did.

Globally, as well as in Germany, ground-breaking synthetic biology research is performed that is pushing for implementation into products. Even though the German Government announced a new bioeconomy strategy – a response the lack of commercialization of SynBio research compared to other countries, there are still questions. Most pressingly, what stops the SynBio Revolution in Germany? And how can we change the status quo towards our benefit?

The answer can be found in SynBio startups and this year’s SynBio World Café focuses the startup activities by asking the question: What stops the SynBio revolution in Germany?

Discussing hurdles, obstacles, and bottlenecks that come with the founding of a new synbio company as well as steering an existing one towards success, this event brings together stakeholders from academia, industry, and legislation to discuss ideas and foster new relationships and discussions. As it’s a digital format, the organisers want to ensure active discussion and therefore have limited number of participants.

You don’t need to be a SynBio expert as this event offers an introduction, and if you are already an expert, you will learn more about the countless transition possibilities.

Register today here. The application is easy and requires only a few minutes and includes some questions that the organisers would like to use as a kick off for discussions.

If you were interested in how you take a step inside the SynBio World Café, you may also be interested in: 

Read: Protera raises $5.6m in Series A financing

Read: Ginkgo Bioworks to use $290m Series E financing to boost cell programming platform.

Download: Bringing synthetic biology innovations to commercial scale report.

Read: Disruptive technology investor invests in bean-free coffee start-up.

Attend: SynBio Markets 2020 (November 2-4, Amsterdam)

Read:  Novalis LifeSciences raises $85m for its first fund and will invest in life science industry, including synthetic biology companies.

Read:  Microbial fermentation pioneers DMC announce $10.3M Series A financing.

Related posts

5 Minutes With…John Husnik from Renaissance BioScience.

Liz Gyekye

Stranger than fiction; the world’s first 3D printed house

Holly Williams

LanzaTech and partners debut products made from recycled industrial pollution.

Luke Upton

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More